Two Sigma Investments’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.95M Sell
54,102
-1,558,907
-97% -$56.2M ﹤0.01% 1813
2025
Q1
$50.2M Sell
1,613,009
-807,394
-33% -$25.1M 0.11% 233
2024
Q4
$61.7M Sell
2,420,403
-8,933
-0.4% -$228K 0.13% 170
2024
Q3
$68.7M Buy
2,429,336
+371,796
+18% +$10.5M 0.15% 156
2024
Q2
$54.3M Buy
2,057,540
+753,881
+58% +$19.9M 0.12% 185
2024
Q1
$39.6M Sell
1,303,659
-807,609
-38% -$24.5M 0.09% 255
2023
Q4
$59.3M Sell
2,111,268
-95,447
-4% -$2.68M 0.14% 180
2023
Q3
$59.9M Buy
2,206,715
+1,075,019
+95% +$29.2M 0.16% 167
2023
Q2
$34.8M Buy
1,131,696
+957,412
+549% +$29.4M 0.09% 265
2023
Q1
$6.28M Sell
174,284
-265,825
-60% -$9.58M 0.02% 753
2022
Q4
$17.4M Sell
440,109
-351,231
-44% -$13.9M 0.05% 378
2022
Q3
$31.8M Buy
791,340
+320,393
+68% +$12.9M 0.11% 232
2022
Q2
$19.8M Buy
470,947
+283,920
+152% +$11.9M 0.07% 323
2022
Q1
$7.29M Buy
187,027
+33,552
+22% +$1.31M 0.02% 724
2021
Q4
$6.12M Buy
+153,475
New +$6.12M 0.01% 836